You have access
Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer
SHINICHIRO KASHIWAGI, YUKA ASANO, WATARU GOTO, KOJI TAKADA, KATSUYUKI TAKAHASHI, TAKAHARU HATANO, TSUTOMU TAKASHIMA, SHUHEI TOMITA, HISASHI MOTOMURA, MASAHIKO OHSAWA, KOSEI HIRAKAWA and MASAICHI OHIRA
Anticancer Research October 2017, 37 (10) 5623-5630;